Loading clinical trials...
Loading clinical trials...
Study to Assess Loteprednol Etabonate Ophthalmic Gel, 0.38% Versus Vehicle Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Conditions
Interventions
Loteprednol Etabonate Gel (BID)
Vehicle Gel (BID)
Locations
1
United States
Bausch & Lomb Incorporated
Bridgewater, New Jersey, United States
Start Date
September 1, 2014
Primary Completion Date
March 1, 2015
Completion Date
March 1, 2015
Last Updated
September 25, 2020
NCT06346132
NCT07482709
NCT07351968
NCT06946290
NCT07041736
NCT07327931
Lead Sponsor
Bausch & Lomb Incorporated
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions